Background
Theresa Garcia used Johnson & Johnson’s talc-based baby powder for nearly five decades before being diagnosed with mesothelioma at age 52 in January 2020. She sued Johnson & Johnson and other defendants alleging their talc products contained asbestos and caused her illness. Garcia died in July 2020, and her daughter, Stephanie Salcedo, continued the litigation as administrator of her mother’s estate, pursuing both Survival Act and wrongful death claims.
After the lawsuit was filed, Johnson & Johnson executed a complex corporate restructuring designed to isolate talc liabilities. The company created Johnson & Johnson Holdco (NA) Inc. to hold assets and LTL Management, LLC to assume talc liabilities. Johnson & Johnson also spun off its consumer health division into Kenvue Inc., which continued selling talc-based baby powder internationally even after Johnson & Johnson discontinued such sales in the U.S. in 2020. Despite these structural changes, talc baby powder remained available for U.S. purchase through 2023.
Following a four-week trial, a jury returned a $45 million verdict for Salcedo’s estate: $30 million under the Survival Act for Garcia’s shortened life expectancy, $3 million for her pain and suffering and loss of normal life, and $12 million in wrongful death damages to surviving family members. The jury apportioned liability at 70% to Kenvue, 15% to Johnson & Johnson, and 15% to Holdco, finding both successor entities to be mere continuations of Johnson & Johnson’s business.
The Court’s Holding
The Illinois Appellate Court affirmed the trial judgment and rejected Johnson & Johnson’s primary argument that the Survival Act does not permit recovery for “shortened life expectancy damages” after a plaintiff’s death. The court held that the critical inquiry is when the injury accrued, not when judgment is entered. Garcia’s injury—the loss of years caused by mesothelioma—occurred while she was alive. Because the injury accrued during her lifetime, her estate may pursue the claim after her death under the Survival Act, which preserves a deceased’s existing claims. The court rejected the dissent’s inference that survival of the plaintiff through trial is a condition of recovery, finding no such requirement in either the statute or controlling precedent.
The court also affirmed the trial court’s evidentiary rulings and the findings on successor liability. Holdco and Kenvue could be held liable as successors-in-interest under Illinois and New Jersey law—not Texas law which governed the restructuring agreement—because they were mere continuations of Johnson & Johnson’s business marketing the same product line. Finally, the court upheld the constitutionality of the prejudgment interest statute as applied to personal injury and wrongful death cases, rejecting Johnson & Johnson’s constitutional challenge.
Key Takeaways
- The Survival Act permits recovery for shortened life expectancy caused by an injury even if the plaintiff dies before trial, as long as the injury accrued during the plaintiff’s lifetime
- Corporate restructuring does not shield successor entities from liability if they are mere continuations of the predecessor company and continue selling the same products
- Survival Act damages and wrongful death damages serve different purposes and do not constitute impermissible double recovery—one compensates the deceased for injury, the other compensates heirs for their loss
- Illinois and New Jersey law, not Texas law, controlled the successor liability analysis despite the restructuring agreement’s choice of law provision
Why It Matters
This decision significantly expands liability in mass tort litigation by permitting Survival Act damages to survive a plaintiff’s death. Defendants can no longer use a plaintiff’s passing as a shield to avoid liability for shortened lifespan injuries. The ruling also demonstrates that sophisticated corporate restructurings—even multi-step arrangements engineered to isolate liabilities—will not protect successor entities if courts find them to be continuations of the predecessor’s business. The court’s application of Illinois and New Jersey law over the restructuring agreement’s contractual choice of Texas law shows that courts will look to the actual substance of the transaction and the state’s policy interests rather than following purely contractual allocations of governing law.
For talc litigation specifically, this case removes major obstacles to recovery in cases where plaintiffs die before trial and exposes successor entities to liability even after corporate restructuring. The affirmed $30 million award for shortened lifespan damages—the lion’s share of the verdict—reflects the court’s view that a defendant should not benefit from conduct that shortened a plaintiff’s life, underscoring heightened accountability for companies that continue marketing products with known hazards.